KATHARINE CALDWELL: Open Payments
NPI 1598990392 · MAGNA, UT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$433 in 25 payments from 15 companies in 2025. Trend: 2023 $326 · 2024 $677 · 2025 $433
Food & beverage: $433
| Company | Payments | Amount |
|---|---|---|
| Boehringer Ingelheim Pharmaceuticals, Inc. | 4 | $74 |
| AstraZeneca Pharmaceuticals LP | 3 | $56 |
| ABBVIE INC. | 2 | $47 |
| GlaxoSmithKline, LLC. | 2 | $33 |
| Gilead Sciences, Inc. | 2 | $31 |
| Novo Nordisk Inc | 2 | $30 |
| Lilly USA, LLC | 2 | $28 |
| Inspire Medical Systems, Inc. | 1 | $24 |
| Astellas Pharma US Inc | 1 | $22 |
| Dexcom, Inc. | 1 | $19 |
Products named: JARDIANCE, VRAYLAR, BREZTRI, INSPIRE, Veozah, Dexcom G6 Transmitter, AREXVY, SX-ONE MICROKNIFE.
Industry payments across UT — which companies pay providers there.
